Protein modification in ethanol toxicity

Adverse Drug Reactions and Toxicological Reviews

Volumn 20, Issue 3, 2001, Pages 133-159

  Worrall, S ^a   Thiele, G M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; AMINO ACID DERIVATIVE; AMINOTRIAZOLE; ANTIBODY; CELL PROTEIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOL OXIDATION; ALCOHOLISM; ANTIBODY PRODUCTION; CHEMICAL REACTION; CHEMICAL STRUCTURE; DNA ADDUCT; DRUG ALCOHOL INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; METABOLITE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN MODIFICATION; REVIEW; TISSUE INJURY;

ANIMALS; ETHANOL; HUMANS; LIVER; LIVER DISEASES, ALCOHOLIC; PROTEIN BINDING; PROTEINS;

EID: 0034792672     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Spin trapping of free radical species produced during the microsomal metabolism of ethanol
2. Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol
3. Red blood cells: A new major modality for acetaldehyde transport from liver to other tissues
4. Transport of acetaldehyde in red blood cells
5. Autoantibodies against cytochromes P450: Role in human diseases
6. Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo
7. Specific targets of covalent drug-protein interactions in hepatocytes and their toxicological significance in drug-induced liver injury
8. Genetic factors in alcohol metabolism and alcoholism
9. The liver and IgA: Immunological, cell biological and clinical implications
10. Immunohistochemical localization of human liver alcohol dehydrogenase in liver tissue, cultured fibroblasts, and HeLa cells
11. Reaction of cysteine and methionine with malondialdehyde
12. Antibodies against malondialdehyde-modified proteins. Induction and ELISA measurement of specific antibodies
13. Validated fluorimetric HPLC analysis of acetaldehyde in hemoglobin fractions separated by cation exchange chromatography: Three new peaks associated with acetaldehyde
14. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake
15. Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics
16. Reaction of malondialdehyde with glycine
17. Binding of metabolically derived acetaldehyde to hepatic proteins in vitro
18. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
19. The formation and stability of imidazolidinone adducts from acetaldehyde and model peptides. A kinetic study with implications for protein modification in alcohol abuse
20. Analysis of adducts formed between acetaldehyde and thiol-containing peptides
21. The identification and partial characterization of acetaldehyde adducts of hemoglobin occurring in vivo: A possible marker of alcohol consumption
22. Evidence for the formation of multiple types of acetaldehyde-haemoglobin adducts
23. Improved separation of acetaldehyde-induced hemoglobin
24. Synthesis of 5-deoxy-D-xylulose-1-phosphate by human erythrocytes
25. Adduct formation between hemoglobin and 5-deoxy-D-xylulose-1-phosphate
26. The role of alcoholism and liver disease in the appearance of serum antibodies against acetaldehyde adducts
27. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis
28. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload
29. Chromatographically identified alcohol-induced haemoglobin adducts as markers of alcohol abuse among women
30. Detection of alpha-hydroxyethyl free radical adducts in the pancreas after chronic exposure to alcohol in the rat
31. Application of the reverse DEPT polarization-transfer pulse sequence to monitor in vitro and in vivo metabolism of 13C-ethanol by 1H-NMR spectroscopy
32. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts
33. Separation of hemoglobin acetaldehyde adducts by high-performance liquid chromatographycation-exchange chromatography
34. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal
35. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: Association of lipid peroxidation with liver fibrogenesis
36. Observation of a new nonfluorescent malondialdehyde-acetaldehyde-protein adduct by 13C NMR spectroscopy
37. Properties of catalase: Catalysis of coupled oxidation of alcohols
38. Conjugation of acetaldehyde with cysteinylglycine, the first metabolite in glutathione breakdown by gammaglutamyltranspeptidase
39. Polylysine modified with malondialdehyde, hydroperoxylinoleic acid and monofunctional aldehydes
40. Detection of reduced acetaldehyde protein adducts using a unique monoclonal antibody
41. Immune mechanisms of alcohol-induced liver disease
42. Cytotoxic T lymphocytes can be generated against acetaldehyde-modified syngeneic cells
43. Purification and characterisation of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits
44. Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis
45. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators
46. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease
47. Metabolism of alcohol: An update
48. Microsomal ethanol-oxidizing system (MEOS): The first 30 years (1968-1998): A review
49. Ethnic and gender differences in ethanol metabolism
50. Metabolism of ethanol and some associated adverse effects on the liver and the stomach
51. Detection of a protein-acetaldehyde adduct in the liver of rats fed alcohol chronically
52. Protein-acetaldehyde adducts in serum of alcoholic patients
53. Measurement of hemoglobin-acetaldehyde adduct in alcoholic patients
54. Covalent binding of acetaldehyde to hepatic proteins during ethanol oxidation
55. Long chain fatty acids and peroxisomal disorders
56. Degenerative chemistry of malondialdehyde. Structure, stereochemistry, and kinetics of formation of enaminals from reaction with amino acids
57. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature
58. Modification of proteins and other biological molecules by acetaldehyde: Adduct structure and functional significance
59. Distribution and turnover of acetaldehyde-modified proteins in liver and blood of ethanol-fed rats
60. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics
61. Hemoglobin-acetaldehyde adducts in human volunteers following acute ethanol ingestion
62. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption
63. Hemoglobin-acetaldehyde adducts are elevated in women carrying alcohol-damaged fetuses
64. Hemoglobin-acetaldehyde adducts in human alcohol abusers
65. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease
66. Early alcoholic liver injury: Formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A
67. The reaction of amines with carbonyls: Its significance in the nonenzymatic metabolism of xenobiotics
68. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases
69. Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix
70. The big book of aldehyde dehydrogenase sequences. An overview of the extended family
71. Pathogenic mechanisms in alcoholic myopathy
72. Enzymology of ethanol and acetaldehyde metabolism in mammals
73. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease
74. Characterisation of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid
75. Reaction of acetaldehyde with hemoglobin
76. Detection of a new acetaldehyde-induced hemoglobin fraction HbA1ach by cation exchange liquid chromatography
77. Association of a haemoglobin-acetaldehyde adduct with questionnaire results on heavy drinkers
78. Substoichiometric inhibition of microtubule formation by acetaldehyde-tubulin adducts
79. Investigation of an acetaldehydehemoglobin adduct in alcoholics
80. Assessment of the role of non-ADH ethanol oxidation in vivo and in hepatocytes from deermice
81. The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells
82. Microsmal ethanol-oxidising system (MEOS): Purification and properties of a rat liver system free of catalase and alcohol dehydrogenase
83. Specificity of N-ethyl lysine of a monoclonal antibody to acetaldehyde-modified proteins prepared under reducing conditions
84. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant
85. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: Possible role in alcoholic cirrhosis
86. Binding of anti-acetaldehyde IgG antibodies to hepatocytes with an acetaldehyde-phosphatidylethanolamine adduct on their surface
87. Experimental liver cirrhosis induced by alcohol and iron
88. Covalent binding of acetaldehyde to proteins: Participation of lysine residues
89. The chemistry of acetaldehyde-protein adducts
90. The role of acetaldehyde adducts in liver injury
91. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration
92. Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation
93. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: Relationship to liver disease severity and alcohol consumption
94. An atypical human alcohol dehydrogenase
95. Atypical human liver alcohol dehydrogenase
96. Metabolic effects of ethanol in the perfused rat liver
97. Ethanol induces the production of antibodies to acetaldehyde-modified epitopes in rats
98. Antibodies against acetaldehyde-modified epitopes: Presence in alcoholic, non-alcoholic liver disease and control subjects
99. Detection of stable acetaldehyde-modified proteins in the livers of ethanol-fed rats
100. Alcohol abusers exhibit a higher IgA response to acetaldehyde-modified proteins
101. Liver damage in ethanol-fed rats injected with acetaldehyde-modified proteins
102. Antibodies from alcoholics, ethanol-fed rats and a rabbit immunised with proteins modified by acetaldehyde in vitro react with liver cytosolic proteins from ethanol-fed rats
103. Anti-acetaldehyde adduct antibodies generated by ethanol-fed rats react with reduced and unreduced acetaldehyde-modified proteins
104. Relationship between alcohol intake and immunoglobulin a immunoreactivity with acetaldehyde-modified bovine serum albumin
105. Comparison of carbohydrate-deficient transferrin, immunoglobulin A antibodies reactive with acetaldehyde-modified protein and acetaldehyde-modified albumin with conventional markers of alcohol consumption
106. Comparison of the formation of proteins modified by direct and indirect ethanol metabolites in the liver and blood of rats fed the Lieber-DeCarli liquid diet
107. Experimental heart muscle damage is associated with increased amounts of reduced- and unreduced-acetaldehyde, malondialdehyde-acetaldehyde protein adducts
108. Protein adducts in Type I and Type II fibre predominant muscles of the ethanol-fed rat: Preferential location in the sarcolemmal and sub-sarcolemmal region
109. Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat
110. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay
111. Human alcohol dehydrogenase family. Functional classification, ethanol/retinol metabolism, and medical implications
112. Heterogeneity of hepatic acetaldehyde adducts in guinea-pigs after chronic ethanol administration: An immunohistochemical analysis with monoclonal and polyclonal antibodies against acetaldehyde-modified protein epitopes
113. Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts
114. Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts
115. Identification of the 37-kd rat liver protein that forms an acetaldehyde adduct in vivo as Δ4-3-ketosteroid 5 beta-reductase
116. Aldehyde dehydrogenase gene superfamily. The 1998 update